PR Newswire
MINNEAPOLIS, June 4, 2018
MINNEAPOLIS, June 4, 2018 /PRNewswire/ -- Bio-Techne
Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive
Officer, will present at the William Blair 38th Annual Growth Stock Conference on Wednesday,
June 13, 2018, at 1:20 p.m. CDT. The conference will be held at the Four Seasons Hotel in
Chicago.
A live webcast of the presentation can be accessed via Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ or through the following link http://wsw.com/webcast/blair54/tech/.
Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high quality purified
proteins––notably cytokines and growth factors, antibodies, immunoassays, as well as biologically active small molecule compounds
and ACD's in-situ hybridization detection products --- which are sold to biomedical researchers and clinical research
laboratories; these operations constitute the core Biotech Division, headquartered in Minneapolis, Minnesota. The Protein Platform Division manufactures innovative protein analysis tools
under the ProteinSimple brand name that greatly automate western blotting and immunoassay practices. The Diagnostics Division
manufactures FDA-regulated controls, calibrators, blood gas and clinical chemistry controls and other reagents for OEM customer
and clinical customers. Bio-Techne products are integral components of scientific investigations into biological processes and
the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical
tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $563
million in net sales in fiscal 2017 and has approximately 1,800 employees worldwide. For more information on Bio-Techne
and its brands, please visit www.bio-techne.com.
Contact:
David Clair, Investor Relations
ir@bio-techne.com
646-277-1266
View original content with multimedia:http://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-william-blair-38th-annual-growth-stock-conference-300658711.html
SOURCE Bio-Techne Corporation
